Inactive Instrument
Sector ratings Charles River Laboratories International, Inc. Xetra
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 200.58 EUR | -7.08% |
|
-10.60% | - |
| 07-29 | Align Technology to add directors, launch review after deal with Elliott | RE |
| 07-20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 49.37B | AAA | ||||||||
| 39.14B | AAA | ||||||||
| 40.85B | - | B | - | - | |||||
| 35.81B | - | ||||||||
| 30.5B | A | ||||||||
| 16.55B | - | - | - | - | |||||
| 16.14B | BBB | ||||||||
| 12.77B | AAA | ||||||||
| 13.71B | AA | ||||||||
| 11.22B | AA | ||||||||
| 10.77B | - | BBB | - | - | |||||
| 10.08B | - | B | - | - | |||||
| 8.9B | AA | ||||||||
| 8.85B | - | A | - | - | |||||
| 8.8B | - | BBB | - | - | |||||
| 8.57B | AAA | ||||||||
| 8.92B | BB | - | |||||||
| 8.58B | - | B | - | - | |||||
| 8.39B | A | ||||||||
| Average | 18.31B | A | |||||||
| Weighted average by Cap. | A |
Select your edition
All financial news and data tailored to specific country editions
















